INNOVATIVE PHARMACEUTICAL BIOTECH L financial statements, including revenue, expenses, profit, and loss
The total revenue of 399 for the last semiannual is 3.73 M HKD, and it's 5.33% lower compared to the previous semiannual. The net income of H1 23 is 193.69 M HKD.